// App-Quantinova.ai

837 : Comprehensive Description of Monoallelic GP1BA Variants Associated with Thrombocytopenia

Researchers

Presenter

  • Rachel C Peck

Principal Investigators

  • Sarah Westbury

  • Lucy Fitzgibbon

  • Neil V Morgan

  • Jose Rivera

  • Walter H. Kahr

  • Karyn Megy

  • Kate Downes

  • Daniel Greene

  • Ernest Turro

  • Andrew David Mumford

Medical Centers

  • Haematology, University of Bristol, Bristol, ENG, United Kingdom

  • School of Clinical Science and School of Cellular and Molecular Medicine, University of Bristol, Bristol, GBR

  • University of Bristol, Bristol, United Kingdom

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CB15/00055-CIBERER, Murcia, Spain

  • Hospital for Sick Children, Toronto, ON, Canada

  • NIHR BioResource–Rare Diseases Consortium, Cambridge, United Kingdom

  • National Institute for Health Research (NIHR) BioResource, Cambridge, United Kingdom

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • University of Cambridge, Cambridge, UK

Locations

  • United Kingdom

  • Spain

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Bernard-Soulier syndrome

  • Thrombocytopenia

  • Trauma

Biomarkers

  • N-Acylethanolamine acid amidase

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A